Bone density phenotypes in mice aneuploid for the Down syndrome critical region

American Journal of Medical Genetics, Part A

Volumn 155, Issue 10, 2011, Pages 2436-2445

  Olson, Lisa E ^a,b   Mohan, Subburaman ^a  

^a LOMA LINDA UNIVERSITY   (United States)

^b UNIVERSITY OF REDLANDS   (United States)

Author keywords

Aneuploidy; Bone density; Chromosome 21; Down syndrome; IGF I; Mice

Indexed keywords

SOMATOMEDIN C;

ANEUPLOIDY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE MINERAL; CONTROLLED STUDY; CORTICAL BONE; DOWN SYNDROME; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR; LUMBAR SPINE; MALE; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TIBIA; TRABECULAR BONE; VOLUMETRY; WEIGHT REDUCTION;

ABSORPTIOMETRY, PHOTON; ANALYSIS OF VARIANCE; ANEUPLOIDY; ANIMALS; BONE DENSITY; CHROMATOGRAPHY, GEL; CHROMOSOMES, MAMMALIAN; DNA PRIMERS; DOWN SYNDROME; FEMUR; GENOTYPE; MICE; MICE, MUTANT STRAINS; PHENOTYPE; POLYMERASE CHAIN REACTION; RADIOIMMUNOASSAY; TOMOGRAPHY, X-RAY COMPUTED;

MUS;

EID: 80053115376     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.34203     Document Type: Article

References (62)

1. Adams J, Bishop N. 2008. DXA in adults and children. In: Rosen C, editor. Primer on the metabolic bone diseases and disorders of mineral metabolism, 7th edition. Washington, D.C.: American Society for Bone and Mineral Research. pp 152-158.
2. Aldridge K, Reeves RH, Olson LE, Richtsmeier JT. 2007. Differential effects of trisomy on brain shape and volume in related aneuploid mouse models. Am J Med Genet Part A 143A: 1060-1070.
3. Angelopoulou N, Matziari C, Tsimaras V, Sakadamis A, Souftas V, Mandroukas K. 2000. Bone mineral density and muscle strength in young men with mental retardation (with and without Down syndrome). Calcif Tissue Int 66: 176-180.
4. Angelopoulou N, Souftas V, Sakadamis A, Mandroukas K. 1999. Bone mineral density in adults with Down's syndrome. Eur Radiol 9: 648-651.
5. Anneren G, Enberg G, Sara VR. 1984. The presence of normal levels of serum immunoreactive insulin-like growth factor 2 (IGF-2) in patients with Down's syndrome. Ups J Med Sci 89: 274-278.
6. Anneren G, Gustavson KH, Sara VR, Tuvemo T. 1990. Growth retardation in Down syndrome in relation to insulin-like growth factors and growth hormone. Am J Med Genet 7: 59-62.
7. Baptista F, Varela A, Sardinha LB. 2005. Bone mineral mass in males and females with and without Down syndrome. Osteoporos Int 16: 380-388.
8. Barreca A, Rasore Quartino A, Acutis MS, Ponzani P, Damonte G, Miani E, Balestra V, Giordano G, Minuto F. 1994. Assessment of growth hormone insulin like growth factor-I axis in Down's syndrome. J Endocrinol Invest 17: 431-436.
9. Baxter LL, Moran TH, Richtsmeier JT, Troncoso J, Reeves RH. 2000. Discovery and genetic localization of Down syndrome cerebellar phenotypes using the Ts65Dn mouse. Hum Mol Genet 9: 195-202.
10. Beamer WG, Donahue LR, Rosen CJ, Baylink DJ. 1996. Genetic variability in adult bone density among inbred strains of mice. Bone 18: 397-403.
11. Beaupied H, Dupuis A, Arlettaz A, Brunet-Imbault B, Bonnet N, Jaffre C, Benhamou CL, Courteix D. 2006. The mode of bone conservation does not affect the architecture and the tensile properties of rat femurs. Biomed Mater Eng 16: 253-259.
12. Belichenko NP, Belichenko PV, Kleschevnikov AM, Salehi A, Reeves RH, Mobley WC. 2009. The "Down syndrome critical region" is sufficient in the mouse model to confer behavioral, neurophysiological, and synaptic phenotypes characteristic of Down syndrome. J Neurosci 29: 5938-5948.
13. Blake GM, Fogelman I. 2007. The role of DXA bone density scans in the diagnosis and treatment of osteoporosis. Postgrad Med J 83: 509-517.
14. Blazek JD, Gaddy A, Meyer R, Roper RJ, Li J. 2010. Disruption of bone development and homeostasis by trisomy in Ts65Dn Down syndrome mice. Bone 48: 275-280.
15. Chettouh Z, Croquette MF, Delobel B, Gilgenkrants S, Leonard C, Maunoury C, Prieur M, Rethoré MO, Sinet PM, Chery M, Delabar JM. 1995. Molecular mapping of 21 features associated with partial monosomy 21: Involvement of the APP-SOD1 region. Am J Hum Genet 57: 62-71.
16. Coussons-Read ME, Crnic LS. 1996. Behavioral assessment of the Ts65Dn mouse, a model for Down syndrome: Altered behavior in the elevated plus maze and open field. Behav Genet 26: 7-13.
17. Crabbe JC, Wahlsten D, Dudek BC. 1999. Genetics of mouse behavior: Interactions with laboratory environment. Science 284: 1670-1672.
18. da Silva VZ, de Franca Barros J, de Azevedo M, de Godoy JR, Arena R, Cipriano G Jr. 2010. Bone mineral density and respiratory muscle strength in male individuals with mental retardation (with and without Down Syndrome). Res Dev Disabil 31: 1585-1589.
19. De Simone R, Puig XS, Gelisse P, Crespel A, Genton P. 2010. Senile myoclonic epilepsy: Delineation of a common condition associated with Alzheimer's disease in Down syndrome. Seizure 19: 383-389.
20. Devriendt K, Vermeesch JR. 2004. Chromosomal phenotypes and submicroscopic abnormalities. Hum Genomics 1: 126-133.
21. Epstein HT. 1978. The effect of litter size on weight gain in mice. J Nutr 108: 120-123.
22. Escorihuela RM, Fernandez-Teruel A, Vallina IF, Baamonde C, Lumbreras MA, Dierssen M, Tobena A, Florez J. 1995. A behavioral assessment of Ts65Dn mice: A putative Down syndrome model. Neurosci Lett 199: 143-146.
23. Fotaki V, Dierssen M, Alcantara S, Martinez S, Marti E, Casas C, Visa J, Soriano E, Estivill X, Arbones ML. 2002. Dyrk1A haploinsufficiency affects viability and causes developmental delay and abnormal brain morphology in mice. Mol Cell Biol 22: 6636-6647.
24. Fujiura GT, Fitzsimons N, Marks B, Chicoine B. 1997. Predictors of BMI among adults with Down syndrome: The social context of health promotion. Res Dev Disabil 18: 261-274.
25. Giustina A, Mazziotti G, Canalis E. 2008. Growth hormone, insulin-like growth factors, and the skeleton. Endocr Rev 29: 535-559.
26. Guijarro M, Valero C, Paule B, Gonzalez-Macias J, Riancho JA. 2008. Bone mass in young adults with Down syndrome. J Intellect Disabil Res 52: 182-189.
27. Harvey N, Dennison E, Cooper C. 2008. Epidemiology of osteoporotic fractures. In: Rosen C, editor. Primer on the metabolic bone diseases and disorders of mineral metabolism, 7th edition. Washington, D.C.: American Society for Bone and Mineral Research. pp 198-203.
28. Hasle H, Clemmensen IH, Mikkelsen M. 2000. Risks of leukaemia and solid tumours in individuals with Down's syndrome. Lancet 355: 165-169.
29. Hawli Y, Nasrallah M, El-Hajj Fuleihan G. 2009. Endocrine and musculoskeletal abnormalities in patients with Down syndrome. Nat Rev Endocrinol 5: 327-334.
30. Hestnes A, Stovner LJ, Husoy O, Folling I, Sjaastad O. 1991. Somatomedin C (insulin-like growth factor 1) in adults with Down's syndrome. J Ment Defic Res 35: 204-208.
31. Holtzman DM, Santucci D, Kilbridge J, Chua-Couzens J, Fontana DJ, Daniels SE, Johnson RM, Chen K, Sun Y, Carlson E, Alleva E, Epstein CJ, Mobley WC. 1996. Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome. Proc Natl Acad Sci USA 93: 13333-13338.
32. Huret JL, Leonard C, Chery M, Philippe C, Schafei-Benaissa E, Lefaure G, Labrune B, Gilgenkrantz S. 1995. Monosomy 21q: Two cases of del(21q) and review of the literature. Clin Genet 48: 140-147.
33. Iida-Klein A, Lu SS, Yokoyama K, Dempster DW, Nieves JW, Lindsay R. 2003. Precision, accuracy, and reproducibility of dual X-ray absorptiometry measurements in mice in vivo. J Clin Densitom 6: 25-33.
34. Isaksson H, Tolvanen V, Finnila MA, Iivarinen J, Tuukkanen J, Seppanen K, Arokoski JP, Brama PA, Jurvelin JS, Helminen HJ. 2009. Physical exercise improves properties of bone and its collagen network in growing and maturing mice. Calcif Tissue Int 85: 247-256.
35. Kao CH, Chen CC, Wang SJ, Yeh SH. 1992. Bone mineral density in children with Down's syndrome detected by dual photon absorptiometry. Nucl Med Commun 13: 773-775.
36. Lee Y, Ha J, Kim HJ, Kim YS, Chang EJ, Song WJ, Kim HH. 2009. Negative feedback inhibition of NFATc1 by DYRK1A regulates bone homeostasis. J Biol Chem 284: 33343-33351.
37. Lewiecki EM. 2010. Bone densitometry and vertebral fracture assessment. Curr Osteoporos Rep 8: 123-130.
38. Lyle R, Bena F, Gagos S, Gehrig C, Lopez G, Schinzel A, Lespinasse J, Bottani A, Dahoun S, Taine L, Doco-Fenzy M, Cornillet-Lefebvre P, Pelet A, Lyonnet S, Toutain A, Colleaux L, Horst J, Kennerknecht I, Wakamatsu N, Descartes M, Franklin JC, Florentin-Arar L, Kitsiou S, Ait Yahya-Graison E, Costantine M, Sinet PM, Delabar JM, Antonarakis SE. 2009. Genotype-phenotype correlations in Down syndrome identified by array CGH in 30 cases of partial trisomy and partial monosomy chromosome 21. Eur J Hum Genet 17: 454-466.
39. Mazess RB, Barden HS, Bisek JP, Hanson J. 1990. Dual-energy x-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition. Am J Clin Nutr 51: 1106-1112.
40. Mohan S, Baylink DJ. 1995. Development of a simple valid method for the complete removal of insulin-like growth factor (IGF)-binding proteins from IGFs in human serum and other biological fluids: Comparison with acid-ethanol treatment and C18 Sep-Pak separation. J Clin Endocrinol Metab 80: 637-647.
41. Mohan S, Richman C, Guo R, Amaar Y, Donahue LR, Wergedal J, Baylink DJ. 2003. Insulin-like growth factor regulates peak bone mineral density in mice by both growth hormone-dependent and -independent mechanisms. Endocrinology 144: 929-936.
42. Moncaster JA, Pineda R, Moir RD, Lu S, Burton MA, Ghosh JG, Ericsson M, Soscia SJ, Mocofanescu A, Folkerth RD, Robb RM, Kuszak JR, Clark JI, Tanzi RE, Hunter DG, Goldstein LE. 2010. Alzheimer's disease amyloid-beta links lens and brain pathology in Down syndrome. PLoS One 5: e10659.
43. Nielsen F, Tranebjaerg L. 1984. A case of partial monosomy 21q22.2 associated with Rieger's syndrome. J Med Genet 21: 218-221.
44. Olson LE, Richtsmeier JT, Leszl J, Reeves RH. 2004. A chromosome 21 critical region does not cause specific Down syndrome phenotypes. Science 306: 687-690.
45. Olson LE, Roper RJ, Sengstaken CL, Peterson EA, Aquino V, Galdzicki Z, Siarey R, Pletnikov M, Moran TH, Reeves RH. 2007. Trisomy for the Down syndrome 'critical region' is necessary but not sufficient for brain phenotypes of trisomic mice. Hum Mol Genet 16: 774-782.
46. Parsons T, Ryan TM, Reeves RH, Richtsmeier JT. 2007. Microstructure of trabecular bone in a mouse model for Down syndrome. Anat Rec (Hoboken) 290: 414-421.
47. Patja K, Pukkala E, Sund R, Iivanainen M, Kaski M. 2006. Cancer incidence of persons with Down syndrome in Finland: A population-based study. Int J Cancer 118: 1769-1772.
48. Pitetti KH, Climstein M, Mays MJ, Barrett PJ. 1992. Isokinetic arm and leg strength of adults with Down syndrome: A comparative study. Arch Phys Med Rehabil 73: 847-850.
49. Reeves RH, Irving NG, Moran TH, Wohn A, Kitt C, Sisodia SS, Schmidt C, Bronson RT, Davisson MT. 1995. A mouse model for Down syndrome exhibits learning and behaviour deficits. Nat Genet 11: 177-184.
50. Rosen CJ. 2004. Insulin-like growth factor I and bone mineral density: Experience from animal models and human observational studies. Best Pract Res Clin Endocrinol Metab 18: 423-435.
51. Rosen CJ, Dimai HP, Vereault D, Donahue LR, Beamer WG, Farley J, Linkhart S, Linkhart T, Mohan S, Baylink DJ. 1997. Circulating and skeletal insulin-like growth factor-I (IGF-I) concentrations in two inbred strains of mice with different bone mineral densities. Bone 21: 217-223.
52. Sakadamis A, Angelopoulou N, Matziari C, Papameletiou V, Souftas V. 2002. Bone mass, gonadal function and biochemical assessment in young men with trisomy 21. Eur J Obstet Gynecol Reprod Biol 100: 208-212.
53. Sara VR, Gustavson KH, Anneren G, Hall K, Wetterberg L. 1983. Somatomedins in Down's syndrome. Biol Psychiatry 18: 803-811.
54. Sepulveda D, Allison DB, Gomez JE, Kreibich K, Brown RA, Pierson RN Jr, Heymsfield SB. 1995. Low spinal and pelvic bone mineral density among individuals with Down syndrome. Am J Ment Retard 100: 109-114.
55. Shapira SK. 1998. An update on chromosome deletion and microdeletion syndromes. Curr Opin Pediatr 10: 622-627.
56. Stewart LS, Persinger MA, Cortez MA, Snead OC 3rd. 2007. Chronobiometry of behavioral activity in the Ts65Dn model of Down syndrome. Behav Genet 37: 388-398.
57. Streeten EA, McBride DJ, Pollin TI, Ryan K, Shapiro J, Ott S, Mitchell BD, Shuldiner AR, O'Connell JR. 2006. Quantitative trait loci for BMD identified by autosome-wide linkage scan to chromosomes 7q and 21q in men from the Amish Family Osteoporosis Study. J Bone Miner Res 21: 1433-1442.
58. Svendsen OL, Haarbo J, Hassager C, Christiansen C. 1993. Accuracy of measurements of body composition by dual-energy x-ray absorptiometry in vivo. Am J Clin Nutr 57: 605-608.
59. Thorleifsson G, Holm H, Edvardsson V, Walters GB, Styrkarsdottir U, Gudbjartsson DF, Sulem P, Halldorsson BV, de Vegt F, d'Ancona FC, den Heijer M, Franzson L, Christiansen C, Alexandersen P, Rafnar T, Kristjansson K, Sigurdsson G, Kiemeney LA, Bodvarsson M, Indridason OS, Palsson R, Kong A, Thorsteinsdottir U, Stefansson K. 2009. Sequence variants in the CLDN14 gene associate with kidney stones and bone mineral density. Nat Genet 41: 926-930.
60. Vary CP, Li V, Raouf A, Kitching R, Kola I, Franceschi C, Venanzoni M, Seth A. 2000. Involvement of Ets transcription factors and targets in osteoblast differentiation and matrix mineralization. Exp Cell Res 257: 213-222.
61. Whitt-Glover MC, O'Neill KL, Stettler N. 2006. Physical activity patterns in children with and without Down syndrome. Pediatr Rehabil 9: 158-164.
62. Yokoyama T, Tamura H, Tsukamoto H, Yamane K, Mishima HK. 2006. Prevalence of glaucoma in adults with Down's syndrome. Jpn J Ophthalmol 50: 274-276.